Literature DB >> 26370634

An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.

Dhaval K Naik1, Matthew G Martelli2, David Hernandez Gonzalo3, Anil K Sharma4, Davinderbir Pannu4.   

Abstract

Olmesartan use has been associated with chronic diarrhoea and weight loss due to severe sprue-like enteropathy, yet this is still not well known among clinicians. We present the unique case of an 84-year-old Filipino woman diagnosed with olmesartan-induced sprue-like enteropathy after an extensive work up for chronic diarrhoea, and without improvement despite multiple empiric treatments for nearly 15 months. Withdrawal of olmesartan resulted in clinical and histological improvement. This case provides further evidence for olmesartan-induced sprue-like enteropathy, and emphasises the importance of its awareness and recognition among gastroenterologists and primary care physicians alike. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26370634      PMCID： PMC4577719          DOI： 10.1136/bcr-2015-212318

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  4 in total

1.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

Review 2.  Systematic review: Sprue-like enteropathy associated with olmesartan.

Authors:  G Ianiro; S Bibbò; M Montalto; R Ricci; A Gasbarrini; G Cammarota
Journal:  Aliment Pharmacol Ther       Date:  2014-05-07       Impact factor: 8.171

3.  Olmesartan-associated enteropathy: results of a national survey.

Authors:  L Marthey; G Cadiot; P Seksik; P Pouderoux; J Lacroute; F Skinazi; B Mesnard; J A Chayvialle; G Savoye; A Druez; D Parlier; V Abitbol; M Gompel; M Eoche; E Poncin; R Bobichon; P Colardelle; P Wils; H Salloum; S Peschard; F Zerbib; B Méresse; N Cerf-Bensussan; G Malamut; F Carbonnel
Journal:  Aliment Pharmacol Ther       Date:  2014-09-09       Impact factor: 8.171

4.  Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.

Authors:  Marisa DeGaetani; Christina A Tennyson; Benjamin Lebwohl; Suzanne K Lewis; Hussein Abu Daya; Carolina Arguelles-Grande; Govind Bhagat; Peter H R Green
Journal:  Am J Gastroenterol       Date:  2013-05       Impact factor: 10.864
  4 in total
  2 in total

1.  Drug Liver Injury Induced by Olmesartan Mediated by Autoimmune-Like Mechanism: A Case Report.

Authors:  Manuel de la Torre-Aláez; Mercedes Iñarrairaegui
Journal:  Eur J Case Rep Intern Med       Date:  2020-01-03

2.  Olmesartan-induced enteropathy associated with cutaneous lesions.

Authors:  Nassim Hammoudi; Marie Dior; Vincent Giraud; Benoit Coffin
Journal:  Clin Case Rep       Date:  2016-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.